FDA says no to AZ’s Fasenra for nasal polyp indication
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
Synopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
KEYPOINTS Sun Pharmaceutical Industries is getting set to bring out its version of molnupiravir, the anti-viral drug from Merck Sharpe Dohme and…
Abstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…
SUMMARY: Iptacopan has been awarded the Innovation Passport for the treatment of C3 glomerulopathy (C3G) and is currently being investigated in a…
This information is provided to assist you if you are new to engaging with the TGA and Australia’s regulatory framework for medical…
CHEMROBOTICS DATABASE CAN HELP THE GENERIC AGROCHEMICAL INDUSTRY IN MANY WAYS ChemRobotics database can help the generic agrochemical industry in many ways.…
399th Central Insecticide Board and Registration Committee: Approvals The Indian Central Insecticides Board and Registration Committee (CIBRC) approved 22 registrations of pesticide…